an increasing trendp = 0.062
At multivariate analysis, an increasing trend of recurrence risk was observed for 21–35 mm nodules treated with RFA (OR 2.57, 95% CI 0.95–6.94, p = 0.062) compared to 15–20 mm nodules, while the recurrence rate was independent of other HCC features such as type of therapy, position and US visibility. 3.6.